Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study
International Journal of Urology · 2023
DOI: 10.1111/iju.15283 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2023. Verfasst von Nobutaka Nishimura und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objectives
Bladder cancer, especially non‐muscle invasive bladder cancer (NMIBC), is one of the most costly cancers owing to its long‐term management. Photodynamic diagnosis‐assisted transurethral resection of bladder tumor (PDD‐TURBT) reduces the risk of intravesical recurrence. However, its impact on healthcare economics in Japan remains unclear. We evaluated the comprehensive medical costs of Japanese healthcare economics regarding PDD‐TURBT.
Methods
This large‐scale, multicenter, retrospective study included a dataset of 1531 patients who were diagnosed with primary NMIBC who underwent initial TURBT between April 2006 and June 2021. A one‐to‐one propensity‐score matching analysis was used for an unbiased comparison based on postTURBT follow‐up periods. The total medical costs, including hospitalization, surgical procedures for TURBT and salvage radical cystectomy, adjuvant intravesical therapies, and follow‐up examinations, were compared between white light (WL)‐TURBT and PDD‐TURBT groups.
Results
After propensity‐score matching, 468 patients each of WL‐ and PDD‐TURBT groups were matched. Total costs were 510 337 128 and 514 659 328 ¥ in WL‐ and PDD‐TURBT groups, respectively. The costs of adjuvant intravesical therapies, follow‐up examinations, and salvage radical cystectomy in PDD‐TURBT group were equivalent to or lower than those in WL‐TURBT group. Furthermore, total costs of high‐ and highest‐risk NMIBC in PDD‐TURBT group were either equivalent or lower compared to those in WL‐TURBT group.
Conclusions
The total costs associated with PDD‐TURBT were higher compared to WL‐TURBT, while there is the potential of PDD‐TURBT to reduce the burden on healthcare economics in limited cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
- Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
- Department of Urology, Kochi Medical School, Nankoku-shi, Kochi, Japan.
- Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
- Department of Urology, JA Yamaguchi Kouseiren Nagato General Hospital, Nagato, Japan.
ORCID-Profile: Makito Miyake, Tatsuki Miyamoto, Yuto Matsushita, Hideo Fukuhara, Hiroaki Matsumoto, Kiyohide Fujimoto
Zitieren
APA
Nishimura, N., Miyake, M., Nakahama, T., Miyamoto, T., Nishimoto, K., Oyama, M., Matsushita, Y., Miyake, H., Fukuhara, H., Inoue, K., Kobayashi, K., Matsumoto, H., Matsuyama, H., Fujii, T., Hirao, Y., & Fujimoto, K. (2023). Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study. International Journal of Urology. https://doi.org/10.1111/iju.15283
Vancouver
Nishimura N, Miyake M, Nakahama T, Miyamoto T, Nishimoto K, Oyama M, et al. Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study. International Journal of Urology. 2023. doi:10.1111/iju.15283
BibTeX
@article{Nishimura2023,
author = {Nishimura, Nobutaka and Miyake, Makito and Nakahama, Tomonori and Miyamoto, Tatsuki and Nishimoto, Koshiro and Oyama, Masafumi and Matsushita, Yuto and Miyake, Hideaki and Fukuhara, Hideo and Inoue, Keiji and Kobayashi, Keita and Matsumoto, Hiroaki and Matsuyama, Hideyasu and Fujii, Tomomi and Hirao, Yoshihiko and Fujimoto, Kiyohide},
title = {Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study},
journal = {International Journal of Urology},
year = {2023},
doi = {10.1111/iju.15283}
}
EUVIMED